| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |